Most Read Articles
6 days ago
A strong belief in the necessity of medication is associated with better adherence to oral disease-modifying antirheumatic drugs (DMARDs) or prednisone, while higher self-efficacy correlates with poor adherence, in a diverse cohort of patients with rheumatoid arthritis (RA), suggests a study.
5 days ago
Low-dose administrations of haloperidol after thoracic surgery does not appear to prevent postoperative delirium, according to a new study.
3 days ago
Percutaneous coronary intervention (PCI) displays comparable rates of mortality and serious composite outcomes but a higher rate of target-vessel revascularization at 10 years relative to coronary artery bypass grafting (CABG) in patients with significant left main coronary artery (LMCA) disease, reports a study. On the other hand, CABG delivers lower mortality and serious composite outcome rates compared with PCI with drug-eluting stents after 5 years.
Pearl Toh, 5 days ago
Apixaban slashes the risk of recurrent venous thromboembolism (VTE) by 90 percent in cancer patients compared with the low-molecular-weight heparin (LMWH) dalteparin, with no increase in major bleeding risk, according to the ADAM VTE study presented at ASH 2018.

Aerobic exercise improves sexual function in women with PCOS

18 Nov 2018

Both continuous (CAT) and intermittent (IAT) aerobic physical training are effective in improving sexual function in women with polycystic ovary syndrome (PCOS), as well as reducing symptoms of anxiety and depression, a recent study has found.

Researchers performed a secondary analysis of a controlled clinical trial where women with PCOS (18–39 years of age) were randomly assigned to receive 16 weeks of CAT (n=23), IAT (n=22) or no training (n=24). Sexual function was measured using the Female Sexual Function Index (FSFI), while depression and anxiety were evaluated using the Hospital Anxiety and Depression Scale (HADS).

After the 16-week training period, significant improvements in total FSFI scores were reported in CAT (estimated difference, –1.8; 95 percent CI, –3.6 to 0.0; p=0.04) and IAT (estimated difference, –3.9; –5.7 to –2.0; p<0.01) groups.

In terms of individual domains, significant improvements were reported for satisfaction (CAT: estimated difference, –0.5; –1.1 to 0.0; p=0.04; IAT: estimated difference, –0.7; –1.2 to –0.1; p=0.02), pain (CAT: estimated difference, –0.56; –1.l0 to 0.0; p=0.02), excitation (IAT: estimated difference, –0.5; –0.9 to –0.2; p<0.01), desire (IAT: estimated difference, –0.8; –1.2 to –0.3; p<0.01), lubrication (IAT: estimated difference, –0.6; –1.0 to –0.2; p<0.01) and orgasm (IAT: estimated difference, –0.9; –1.4 to –0.5; p<0.01).

Similarly, symptoms of anxiety (CAT: estimated difference, 1.8; 0.4–3.2; p=0.01; IAT: estimated difference, 2.2; 0.7–3.6; p<0.01) and depression (CAT: estimated difference, 2.1; 0.7–3.5; IAT: estimated difference, 1.6; 0.2–3.0; p=0.02) significantly improved after the exercise period.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
A strong belief in the necessity of medication is associated with better adherence to oral disease-modifying antirheumatic drugs (DMARDs) or prednisone, while higher self-efficacy correlates with poor adherence, in a diverse cohort of patients with rheumatoid arthritis (RA), suggests a study.
5 days ago
Low-dose administrations of haloperidol after thoracic surgery does not appear to prevent postoperative delirium, according to a new study.
3 days ago
Percutaneous coronary intervention (PCI) displays comparable rates of mortality and serious composite outcomes but a higher rate of target-vessel revascularization at 10 years relative to coronary artery bypass grafting (CABG) in patients with significant left main coronary artery (LMCA) disease, reports a study. On the other hand, CABG delivers lower mortality and serious composite outcome rates compared with PCI with drug-eluting stents after 5 years.
Pearl Toh, 5 days ago
Apixaban slashes the risk of recurrent venous thromboembolism (VTE) by 90 percent in cancer patients compared with the low-molecular-weight heparin (LMWH) dalteparin, with no increase in major bleeding risk, according to the ADAM VTE study presented at ASH 2018.